Who Exports Budesonide from India — 275 Suppliers Behind a $190.5M Market
India's budesonide export market is supplied by 275 active exporters who collectively shipped $190.5M across 9,145 shipments. CIPLA LIMITED leads with a 87.8% market share, followed by SUN PHARMACEUTICAL INDUSTRIES LIMITED and ZYDUS LIFESCIENCES LIMITED. The top 5 suppliers together control 94.8% of total export value, reflecting a concentrated market structure.
Top Budesonide Exporters from India — Ranked by Export Value
CIPLA LIMITED is the leading budesonide exporter from India, holding a 87.8% share of the $190.5M market across 9,145 shipments from 275 exporters. The top 5 suppliers — CIPLA LIMITED, SUN PHARMACEUTICAL INDUSTRIES LIMITED, ZYDUS LIFESCIENCES LIMITED, AHLCON PARENTERALS (INDIA) LIMITED, AHLCON PARENTERALS INDIA LIMITED — collectively control 94.8% of total export value, indicating a highly concentrated market. Individual shares are: CIPLA LIMITED (87.8%), SUN PHARMACEUTICAL INDUSTRIES LIMITED (4.1%), ZYDUS LIFESCIENCES LIMITED (1.3%), AHLCON PARENTERALS (INDIA) LIMITED (1.0%), AHLCON PARENTERALS INDIA LIMITED (0.6%).
Top Budesonide Exporters from India
Ranked by export value · 275 active suppliers · Indian Customs (DGFT) data
| # | Supplier & Formulations | Value | Ctry. | Share |
|---|---|---|---|---|
| 1 | CIPLA LIMITED PULMIREMA RESPULES 0.25MG/MLBUDECORT 0.25MG/ML RESPULESPULMIREMA RESPULES 0.5MG/ML | $167.3M | 31 | 87.8% |
| 2 | SUN PHARMACEUTICAL INDUSTRIES LIMITED | $7.8M | 3 | 4.1% |
| 3 | ZYDUS LIFESCIENCES LIMITED FORACORT400 DP CAPS | $2.4M | 7 | 1.3% |
| 4 | AHLCON PARENTERALS (INDIA) LIMITED BUDESONIDE SUSPENSION FOR NEBULIZATION 2BUDESONIDE NEBULIZATION SUSPENSION BP 250MCG/ML NOSBUDESONIDE NEBULISER SUSPENSION BP NOS | $1.9M | 2 | 1.0% |
| 5 | AHLCON PARENTERALS INDIA LIMITED BUDESONIDE SUSPENSION FOR NEBULIZATION 2BUDESONIDE NEBULIZATION SUSPENSION BP 250MCG/ML NOSBUDESONIDE NEBULISER SUSPENSION BP NOS | $1.1M | 2 | 0.6% |
| 6 | AXA PARENTERALS LIMITED BUDESONIDE SUSPENSION FOR NEBULIZATION 2BUDESONIDE NEBULIZATION SUSPENSION BP 250MCG/ML NOSBUDESONIDE NEBULISER SUSPENSION BP NOS | $1.0M | 9 | 0.5% |
| 7 | MEDISPRAY LABORATORIES PRIVATE LIMITED | $939.0K | 1 | 0.5% |
| 8 | CADILA HEALTHCARE LIMITED FORACORT400 DP CAPS | $787.7K | 5 | 0.4% |
| 9 | ALTHEA PHARMA PRIVATE LIMITED BUDESONIDE SUSPENSION FOR NEBULIZATION 2BUDESONIDE NEBULIZATION SUSPENSION BP 250MCG/ML NOSBUDESONIDE NEBULISER SUSPENSION BP NOS | $578.6K | 1 | 0.3% |
| 10 | MACLEODS PHARMACEUTICALS LTD | $511.6K | 9 | 0.3% |
| 11 | GLENMARK PHARMACEUTICALS LIMITED | $489.4K | 2 | 0.3% |
| 12 | NOBLE WELLNESS PRIVATE LIMITED | $372.9K | 2 | 0.2% |
| 13 | MEDISPRAY LABORATORIES PVT LTD | $362.9K | 1 | 0.2% |
| 14 | LEGENCY REMEDIES PRIVATE LIMITED BUDESONIDE SUSPENSION FOR NEBULIZATION 2BUDESONIDE NEBULIZATION SUSPENSION BP 250MCG/ML NOSBUDESONIDE NEBULISER SUSPENSION BP NOS | $333.0K | 3 | 0.2% |
| 15 | MILTON LIFECARE PRIVATE LIMITED | $299.6K | 1 | 0.2% |
Related Analysis
Supplier Certification & Compliance Matrix
FDA, WHO-GMP, and EU GMP status for top Budesonide exporters
| Supplier | US FDA | WHO-GMP | EU GMP | ANDAs | Notes |
|---|---|---|---|---|---|
| CIPLA LIMITED | Approved | Yes | Yes | Multiple | Cipla has received FDA approvals for various medications and holds WHO-GMP and E |
| SUN PHARMACEUTICAL INDUSTRIES LIMITED | Approved | Yes | Yes | Multiple | Sun Pharma has FDA approvals and holds WHO-GMP and EU GMP certifications. |
| ZYDUS LIFESCIENCES LIMITED | Approved | Yes | Yes | Multiple | Zydus Lifesciences has FDA approvals and holds WHO-GMP and EU GMP certifications |
| GLENMARK PHARMACEUTICALS LIMITED | Approved | Yes | Yes | Multiple | Glenmark Pharmaceuticals has FDA approvals and holds WHO-GMP and EU GMP certific |
| CADILA HEALTHCARE LIMITED | Approved | Yes | Yes | Multiple | Cadila Healthcare has FDA approvals and holds WHO-GMP and EU GMP certifications. |
| MACLEODS PHARMACEUTICALS LTD | Approved | Yes | Yes | Multiple | Macleods Pharmaceuticals has FDA approvals and holds WHO-GMP and EU GMP certific |
| LINCOLN PHARMACEUTICALS LIMITED | Not Listed | Yes | Yes | Not Applicable | Lincoln Pharmaceuticals holds WHO-GMP and EU GMP certifications. |
TransData Nexus reviewed the regulatory standing of 7 leading Budesonide exporters from India. 6 hold US FDA facility approvals, 7 maintain WHO-GMP certification, and 7 are EU GMP compliant. For regulated markets (US, EU, Australia), prioritise suppliers with active FDA or EU GMP approvals. For semi-regulated markets (Africa, ASEAN, Latin America), WHO-GMP certification is the minimum recommended standard.
Certification status compiled from publicly available regulatory databases including FDA Orange Book, WHO Prequalification database, and EMA GMP registry. Buyers should independently verify compliance status with the relevant regulatory authority before placing orders.
TransData Nexus Research · Mar 2026
Manufacturing Hub Analysis — Vendor Proximity
India's pharmaceutical clusters relevant to Budesonide sourcing
1Hyderabad — Bulk Drug Capital
Hyderabad, often referred to as the "Bulk Drug Capital of India," hosts over 800 pharmaceutical companies, including major players like Dr. Reddy’s Laboratories and Aurobindo Pharma. The city's Genome Valley is India's first biotech cluster, fostering advanced R&D infrastructure and a skilled talent pool from institutions such as the National Institute of Pharmaceutical Education and Research (NIPER). This robust ecosystem positions Hyderabad as a key hub for the production of Active Pharmaceutical Ingredients (APIs) like Budesonide.
2Ahmedabad-Vadodara — Formulations Hub
The Ahmedabad-Vadodara corridor in Gujarat contributes nearly 28% of India's pharmaceutical production. Home to companies like Zydus Lifesciences Limited and Cadila Healthcare Limited, this region boasts a mature pharma ecosystem supported by strong infrastructure, including ports and transportation networks. Its specialization in formulations makes it a strategic location for manufacturing finished Budesonide products.
3Mumbai-Thane-Raigad — Export Gateway
The Mumbai-Thane-Raigad belt in Maharashtra serves as a critical export gateway for pharmaceuticals. With 929 pharmaceutical units, the region's proximity to major ports facilitates efficient international distribution. Companies like Macleods Pharmaceuticals Ltd operate here, leveraging the area's logistical advantages to export products such as Budesonide to global markets.
4Baddi-Nalagarh — Tax Incentive Zone
Baddi-Nalagarh in Himachal Pradesh is Asia's largest pharmaceutical hub, housing over 1,000 manufacturing units, including those of Cipla and Cadila Healthcare. The region's growth has been propelled by favorable government policies, world-class infrastructure, and proximity to key markets. Baddi's dominance is attributed to its ability to cater to all segments of the pharmaceutical value chain while maintaining international standards for quality and compliance.
5Sourcing Recommendations
- Diversify Supplier Base: While CIPLA LIMITED dominates Budesonide exports, consider engaging with other manufacturers like SUN PHARMACEUTICAL INDUSTRIES LIMITED and ZYDUS LIFESCIENCES LIMITED to mitigate supply chain risks.
- Leverage Regional Strengths: Utilize Hyderabad for API sourcing, Ahmedabad-Vadodara for formulations, and Mumbai-Thane-Raigad for export logistics to optimize the supply chain.
- Monitor Regulatory Compliance: Ensure suppliers adhere to international quality standards and possess necessary certifications to maintain product integrity and market access.
- Assess Infrastructure and Incentives: Evaluate the benefits of operating in tax incentive zones like Baddi-Nalagarh to reduce costs and enhance profitability.
Recent M&A, Collaborations & Capacity Expansions
Industry developments among top Budesonide exporters from India
Zydus Lifesciences Limited — Zydus acquires Amplitude Surgical for €256.8 million
In October 2024, Zydus Lifesciences acquired 85.6% of France-based Amplitude Surgical for €256.8 million, marking its entry into the medical devices sector. - IMPACT: This diversification may lead to a strategic shift in resource allocation, potentially affecting Budesonide export volumes.
Impact: This diversification may lead to a strategic shift in resource allocation, potentially affecting Budesonide export volumes.
Cipla Limited — Cipla acquires Ivia Beaute's cosmetics business for ₹130 crore
In April 2024, Cipla acquired Ivia Beaute Pvt Ltd's cosmetics and personal care distribution and marketing business for ₹130 crore, expanding its consumer healthcare portfolio. - IMPACT: This acquisition diversifies Cipla's product offerings, which may influence its focus on pharmaceutical exports, including Budesonide.
Impact: This acquisition diversifies Cipla's product offerings, which may influence its focus on pharmaceutical exports, including Budesonide.
Sun Pharmaceutical Industries Limited — Sun Pharma partners with Royal Challengers Bengaluru as principal sponsor
In February 2026, Sun Pharma entered a three-year partnership with the Royal Challengers Bengaluru as its principal sponsor and health partner for the Indian Premier League. - IMPACT: While this collaboration enhances brand visibility, it is unlikely to have a direct impact on Budesonide export volumes.
Impact: While this collaboration enhances brand visibility, it is unlikely to have a direct impact on Budesonide export volumes.
Common Questions — Budesonide Suppliers from India
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which budesonide supplier from India is the most reliable for bulk orders?
Based on shipment frequency and export consistency, CIPLA LIMITED leads with 1,060 recorded shipments worth $167.3M. SUN PHARMACEUTICAL INDUSTRIES LIMITED (166 shipments) and ZYDUS LIFESCIENCES LIMITED (78 shipments) are also established high-volume exporters.
Q How many budesonide manufacturers are there in India?
India has 275 active budesonide exporters with a combined export market of $190.5M across 9,145 shipments to 115 countries. The top 5 suppliers hold 94.8% of total export value.
Q What certifications should I verify?
Verify: WHO-GMP certification (most markets), US FDA approval (United States), EU GMP certificate (EU/EEA), and Free Sale Certificate from CDSCO. Always request a Certificate of Analysis (CoA) and Certificate of Origin (CoO).
Q What is the typical price range for budesonide from India?
Average FOB unit price: $6.44 per unit, ranging from $0.00 to $1742.05. Average shipment value: $20.8K.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Supplier Ranking: 275 verified Indian exporters of Budesonide ranked by capped export value from DGFT shipping bill records.
- 2.Export Value Analysis: Total export value aggregated from 9,145 individual shipping bill records. Values are FOB in USD.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
- 4.Market Concentration: Supplier market share and geographic reach analyzed across 115 destination countries.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
9,145 Verified Shipments
275 exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists